No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty: A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

Lignende værker

• Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial
  af: Sköldenberg, Olof, et al.
  Udgivet: (2016)
• Good stability but high periprosthetic bone mineral loss and late-occurring periprosthetic fractures with use of uncemented tapered femoral stems in patients with a femoral neck fracture: A 5-year follow-up of 31 patients using RSA and DXA
  af: Sköldenberg, Olof G, et al.
  Udgivet: (2014)
• Lower periprosthetic bone loss and good fixation of an ultra-short stem compared to a conventional stem in uncemented total hip arthroplasty: A randomized clinical trial with DXA and RSA in 51 patients
  af: Salemyr, Mats, et al.
  Udgivet: (2015)
• Cemented compared to uncemented femoral stems in total hip replacement for displaced femoral neck fractures in the elderly: study protocol for a single-blinded, randomized controlled trial (CHANCE-trial)
  af: Chammout, Ghazi, et al.
  Udgivet: (2016)
• High risk of early periprosthetic fractures after primary hip arthroplasty in elderly patients using a cemented, tapered, polished stem: An observational, prospective cohort study on 1,403 hips with 47 fractures after mean follow-up time of 4 years
  af: Brodén, Cyrus, et al.
  Udgivet: (2015)